NCI Events

DCP Early Career Scientist Spotlight Research Seminar Series

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) has created the DCP Early Career Scientist Spotlight Research Seminar Series to highlight nominated early career scientists who are advancing research within the areas supported by DCP. The overall goal of this ongoing seminar series is to increase visibility and provide recognition to these DCP Early Career Scientists.

Workshop on Synthetic Biology for Molecular Imaging in Cancer

To facilitate the reach and impact of synthetic biology on molecular cancer imaging, the Cancer Imaging Program in the NCI plans to convene a two-day virtual workshop (April 22-23, 2024) on Synthetic Biology for Molecular Imaging in Cancer. The workshop will seek input from experts in the scientific community to evaluate the potential of synthetic bioengineering methodologies in advancing molecular cancer imaging for research and clinical application. The overarching goal is to identify new opportunities, delineate the key challenges, and develop strategies to overcome these challenges. We envision this workshop will be a steppingstone to spur discussion and collaboration among scientists to match synthetic bioengineering design principles with agent and tool development in cancer imaging.

NCI Emerging Technologies Seminar Series

This seminar series will highlight novel technologies that could transform cancer research and clinical care. These virtual monthly seminars will each showcase an innovative technology from an NCI-supported investigator, including the challenges and opportunities of technology development and how the tools can be used to advance cancer research. The seminar occurs at the end of every month on a Tuesday at 2:00pm ET and is held through Zoom.

Cancer Moonshot Seminar Series

The upcoming presentations will showcase research from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report. They will inform the community about the progress of Cancer Moonshot-funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives.

20th Annual CCR and DCEG Staff Scientist and Staff Clinician Retreat

The National Cancer Institute's Center for Cancer Research (CCR), Division of Cancer Epidemiology and Genetics (DCEG), and the Frederick National Laboratory for Cancer Research (FNLCR) will hold their 19th Annual Retreat for all Staff Scientists and Staff Clinicians on Monday, April 24, 2023. This is an opportunity to highlight the amazing work performed by Staff Scientists and Staff Clinicians and to foster future collaborations.

Annual HIV DRP Think Tank Meeting

The HIV Dynamics and Replication Program (HIV DRP), Center for Cancer Research (CCR), National Cancer Institute (NCI), will hold their 27th Annual DRP Think Tank Meeting, on Tuesday, April 30, 2024.

Annual NCI DCEG Fellows' Training Symposium

The 16th Annual DCEG Fellows' Training Symposium, themed "Genethics: advancing ethics and equity across the genetics landscape", is proudly announced by the organizing committee and DCEG Office of Education. DCEG is part of the Intramural Program of the National Cancer Institute, NIH.

SCLC Consortium Meeting

This hybrid meeting will host national and international experts in the dynamic field of SCLC research. It will cover the most recent developments in SCLC biology, models, tumor heterogeneity and plasticity, immunology and immunotherapy, new therapy targets, and treatment resistance. The sessions will aim to develop collaborative approaches to address key questions in the field and define promising scientific areas.

NCI Program Staff and patient advocates with an interest in SCLC are also invited guests. We hope this venue will enable data sharing with the intent to offer many new collaborative opportunities within the SCLC community.

12th Annual Symposium on Global Cancer Research

The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually as a satellite meeting to the 14th Annual Consortium of Universities for Global Health (CUGH) Global Health Conference. The Symposium is organized through a collaboration with the US National Cancer Institute Center for Global Health; CUGH; the American Society of Clinical Oncology (ASCO); the American Association for Cancer Research (AACR); the African Organisation for Research and Training in Cancer (AORTIC); the American Society of Preventive Oncology (ASPO); and Red de Institutos e Instituciones Nacionales de Cáncer – Sociedad Latino Americana y del Caribe De Oncología Médica (RINC-SLACOM).

Rare Cancers Prevention and Interception Workshop

The main goals of the workshop are to: 1) Identify challenges and knowledge gaps and explore research opportunities in rare cancers research. 2) Identify research gaps and develop strategic planning with emphasis on understudied research areas in rare cancers. 3) Explore important research questions that will lead to developing better ways of prevention and interception against rare cancers. 4) Finding ways to facilitate networking (researchers, clinicians, patient advocates) among the stakeholders and engage them for the benefit of the patient community.

Implementation Science Centers in Cancer Control

The ISC3 Annual Grantee Meeting will focus on sustainability, community partnerships, and building implementation science structure in low- and middle-income countries. The meeting will feature presentations, interactive breakouts, and discussion sessions to encourage more engagement and discussion on Building and Sustaining Implementation Science Structure. 

NCI Patient Advocate Steering Committee Meeting: Training New Advocate “Stars”

The PASC is dedicated to ensuring the effective integration of advocates within the NCI Scientific Steering Committees and Task Forces, specifically in the development, implementation, and monitoring of clinical trials. The conference will bring together all advocate representatives to the NCI Scientific Steering Committees and Task Forces to conduct strategic discussions around how to ensure comprehensive consideration of the patient community during clinical trial development and evaluation.

Immuno-Oncology Translational Network (IOTN) Capstone Meeting

The Immuno-Oncology Translational Network (IOTN) Capstone meeting will highlight scientific accomplishments across the IOTN. This will be a hybrid meeting held May 14-15, 2024 with both virtual and in person (Masur Auditorium, Building 10, NIH Bethesda main campus).

COMETS Analytics Workshop

This virtual workshop entitled “Metabolomic epidemiology on a global scale: accelerating discovery and enhancing rigor and reproducibility of single cohort and meta-analyses” will discuss exciting new developments within COMETS Analytics and review the capabilities and utility of the platform when applied to single cohort and meta-analysis investigations.

Think Tank on Advancing Gastric Cancer Prevention

The aim of the Think Tank is to provide a forum for a multidisciplinary group of gastric cancer experts to review the state of the science and collaboratively identify critical knowledge gaps.

Co-clinical Imaging Research Resource Program (CIRP) Annual Meeting

The National Cancer Institute (NCI) will host the Co-Clinical Imaging Research Resource Program (CIRP) Annual Hybrid Meeting 2024. Join us on May 20 - 21, 2024 in-person at NCI Shady Grove Campus or virtually via WebEx to learn about how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers and applications of co-clinical imaging to oncology precision medicine.

Sex and Gender Differences in Cancer Workshop Series

This series of virtual workshops brings together those that are interested in sex and gender differences in cancer in the areas of basic biology, genomics, epigenetics, immunology, clinical/translational science, as well as population science. Goals of the series are to not only learn about the latest research findings but to also identify gaps in our knowledge, identify potential collaborative opportunities, and learn best practices for methodology and reporting.

NCI Cancer Prevention Clinic Steering Committee Retreat

The purpose of this retreat is to review the progress to date and discuss strategic goals, operations and funding opportunities.

Cancer AI Conversations

“Cancer AI Conversations” are bimonthly, 1-hour virtual events featuring timely topics related to the application of artificial intelligence in cancer research. Each event features short talks from 2-4 subject matter experts offering diverse perspectives on the session topic. These talks will be followed by a moderated panel discussion.

Annual Lung SPORE Workshop

The NCI Translational Research Program is delighted to announce the Annual Lung Cancer SPORE Workshop which will take place June 12-13, 2024 in New Haven, CT.  The Workshop will be hosted by the Yale SPORE in Lung Cancer led by Katerina Politi, PhD, and Roy S. Herbst, MD, PhD. The workshop will recognize and celebrate the 20th anniversary of the discovery of EGFR mutations in lung cancer and how this has transformed the diagnosis and treatment of the disease. This hybrid meet encourages collaborations between clinical and scientific investigators and will continue the tradition of reporting on the latest developments in lung cancer translational research.

Targeted Delivery Interest Group Webinar Series

The Targeted Delivery Interest Group (TDIG) is a NIH multi-institutional team that champions targeted delivery of therapeutics to different organs for selective and effective treatments with reduced harmful effects.

DCCPS Fellows Symposium

The National Cancer Institute (NCI) Division of Cancer Control and Population Sciences (DCCPS) is hosting the 2024 DCCPS Fellows Symposium on July 24 and 25, from approximately noon until 5:00 p.m. each day at NCI Shady Grove with opportunities to attend virtually.

Translational Advances in Cancer Prevention Agent Development (TACPAD) – 3rd Biennial Virtual Meeting

The main goals of the meeting are to: 1) Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research, 2) Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and 3) Inform the research community of the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.